Health-related quality of life for pembrolizumab (pembro) plus ipilimumab (ipi) versus pembro plus placebo in patients with metastatic NSCLC with PD-L1 tumor proportion score ? 50%: KEYNOTE-598.

Basit Öğe Kaydı
dc.authoridBoyer, Michael/0000-0002-0452-2987;
dc.authorwosidBoyer, Michael/GZG-2105-2022
dc.authorwosidYumuk, Perran Fulden/A-6189-2018
dc.contributor.authorSendur, Mehmet Nahit
dc.contributor.authorReck, Martin
dc.contributor.authorRodriguez-Abreu, Delvys
dc.contributor.authorPark, Keunchil
dc.contributor.authorLee, Dae Ho
dc.contributor.authorCicin, Irfan
dc.contributor.authorYumuk, Perran Fulden
dc.date.accessioned2024-06-12T11:22:27Z
dc.date.available2024-06-12T11:22:27Z
dc.date.issued2021
dc.departmentTrakya Üniversitesien_US
dc.descriptionVirtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 04-08, 2021 -- ELECTR NETWORKen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.description.sponsorshipMerck Sharp Dohme Corp.en_US
dc.description.sponsorshipMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USAen_US
dc.identifier.doi10.1200/JCO.2021.39.15_suppl.9038
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/JCO.2021.39.15_suppl.9038
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25940
dc.identifier.volume39en_US
dc.identifier.wosWOS:000708120605019en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleHealth-related quality of life for pembrolizumab (pembro) plus ipilimumab (ipi) versus pembro plus placebo in patients with metastatic NSCLC with PD-L1 tumor proportion score ? 50%: KEYNOTE-598.en_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu